1. Home
  2. Companies
  3. Cardiff Oncology
  4. Financial Ratios
  5. Operating Cycle
Cardiff Oncology logo
Cardiff Oncology CRDF
$ 1.72 -3.91%

Quarterly report 2026-Q1
added 05-14-2026

report update icon

Cardiff Oncology Operating Cycle 2011-2026 | CRDF

Annual Operating Cycle Cardiff Oncology

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000
294 284 396 617 435 - - 162 55.7 96.2 115 73.9 - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
617 55.7 253

Quarterly Operating Cycle Cardiff Oncology

2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- 297 351 493 - 296 236 152 - 116 354 795 - 319 224 605 - 373 353 450 - 1.82 K 1.82 K 663 - 346 266 262 - 178 423 513 38 341 69 85.2 135 103 88.7 75.4 114 157 183 55.9 92.4 90.4 93 55.8 153 165 147 94.8 94.3 72.7 370 357 - 164 113 -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
1.82 K 38 304

Operating Cycle of other stocks in the Biotechnology industry

Issuer Operating Cycle Price % 24h Market Cap Country
FSD Pharma FSD Pharma
HUGE
 		3.11 K - 5743.5 % $ 69.7 M canadaCanada
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
 		1.94 K - 1.35 % $ 17.8 M chinaChina
AgeX Therapeutics AgeX Therapeutics
AGE
 		186 - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
 		271 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
 		12.8 - - $ 40.3 B usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
 		206 - - $ 96.9 B britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		32 - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
 		245 - -18.52 % $ 27.3 M britainBritain
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
 		104 - - - russiaRussia
Celyad Oncology SA Celyad Oncology SA
CYAD
 		64.4 - - $ 12.5 M belgiumBelgium
Berkeley Lights Berkeley Lights
BLI
 		349 - -7.31 % $ 87 M usaUSA
Generation Bio Co. Generation Bio Co.
GBIO
 		47.6 - - $ 344 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
 		129 $ 1.72 3.94 % $ 458 M britainBritain
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		61.7 - - $ 7.46 M israelIsrael
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
 		185 - -4.36 % $ 27 M usaUSA
Compugen Ltd. Compugen Ltd.
CGEN
 		400 $ 2.87 9.77 % $ 268 M israelIsrael
Anika Therapeutics Anika Therapeutics
ANIK
 		235 $ 14.85 -1.13 % $ 213 M usaUSA
Advaxis Advaxis
ADXS
 		3.28 K - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
 		115 - 5.93 % $ 314 M canadaCanada
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		126 - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
 		17.9 - 1.93 % $ 17.4 M usaUSA
Aptinyx Aptinyx
APTX
 		46.9 - -39.0 % $ 4.57 M usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
 		656 $ 1.64 4.46 % $ 192 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
 		40.8 - -0.23 % $ 916 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
 		291 $ 20.71 -1.43 % $ 2.64 B usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
 		154 - - $ 2.17 B usaUSA
Aravive Aravive
ARAV
 		16.8 - -13.39 % $ 1.45 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
 		59 - 17.91 % $ 11.1 M usaUSA